Rada Savic, PhD

Rada Savic
Global Health Sciences Faculty Affiliate

Phone: 415-502-0640
UCSF Box: 2911
Email: [email protected]
UCSF Profile

Project Sponsor
Location(s) Topics Start End
Phase III Quinolone Meta-Analysis United States Drug and Diagnostics Development
Optimal MDR treatment in children Indonesia Tuberculosis, Pediatrics
Mechanism-Based Integrative Pharmacology Model for Tuberculosis United States Tuberculosis, Pharmacology and Drug Treatment
Optimal MDR treatment in children South Africa Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
Lesion Drug Penetration and Translational Modeling Bill & Melinda Gates Foundation United States Tuberculosis, Drug and Diagnostics Development
Adherence Monitoring impact in Global Health - Planning Grant Bill & Melinda Gates Foundation Uganda Tuberculosis, Treatment Adherence
Clinical Trial Simulation efforts for upcoming HIV therapeutic development. Bill & Melinda Gates Foundation United States HIV/AIDS
Development of Rectal Enema As Microbicide (DREAM) Johns Hopkins University United States HIV/AIDS, Pharmacology and Drug Treatment
Integrative Pharmacology Approach to Understand Mechanisms of Tuberculosis Drug Resistance Johns Hopkins University United States Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development
Pharmacostatistical Modeling and Simulation of Randomized Clinical PrEP Trials Johns Hopkins University United States HIV/AIDS, Systematic Reviews and Guideline Development, Treatment Adherence
Nonlinear Mixed Effects Modeling of Rifapentine Pharmacokinetics Sanofi-Aventis Group Uganda Tuberculosis, Pharmacology and Drug Treatment
Impact of Pregnancy on Tuberculosis Boston Medical Center Corporation India Tuberculosis, Women's Health, Labor and Delivery, Newborn and Infant Health
Nonlinear Mixed Effects Modeling of Rifapentine in Children National Foundation for the CDC and Prevention Kenya; South Africa; China; Viet Nam; Peru Tuberculosis, Pediatrics
Multiscale System Pharmacology Disease Platform for Tuberculosis PhRMA Foundation United States Tuberculosis
Novel Biomarkers to Shorten TB Treatment Rutgers University United States Tuberculosis
Impact of Pregnancy on Tuberculosis Rutgers University Uganda Tuberculosis, Pharmacology and Drug Treatment, Women's Health, Labor and Delivery, Newborn and Infant Health
De Facto Monotherapy during Multidrug Tuberculosis Treatment and Emergence of Resistance Rutgers University United States Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis
Lesion-centric imaging and PK-PD of pyrazinamide for TB/HIV co-infection Rutgers University United States Tuberculosis
Biostatistical analysis of Mycobacterium Tuberculosis Biomarkers for Diagnosis and Cure Catalysis Foundation for Health, Inc United States Tuberculosis, Drug and Diagnostics Development